Tag:
Linkage Biosciences
Latest Headlines
Latest Headlines
Rib-X gets Phase II results, $25M in financing
It was a good news day at New Haven, CT-based Rib-X Pharmaceuticals. First, the company announced positive Phase II results from a Phase II clinical trial of delafloxacin (RX-3341) for complicated
